AMA counts to 10 before voting drug shortages position

Unlike the many individual patients who report feeling powerless when they are unable to get drugs they need, doctors are plying their strength in numbers under the banner of the American Medical Association to catalyze a solution. They've voted their support for FDA and Congress to require contingency production plans of the makers of medically necessary drugs to ensure continuous supply. And members agreed to support financial incentives for drugmakers to continue production of scarce medicines, but only after ruling out the idea of financial penalties for those that don't promptly attempt to rectify shortages. Story

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.